Norges Bank’s Madrigal Pharmaceuticals MDGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$53.4M Buy
+176,467
New +$53.4M 0.01% 925
2025
Q1
Sell
-115,092
Closed -$35.5M 988
2024
Q4
$35.5M Buy
+115,092
New +$35.5M ﹤0.01% 1090
2024
Q3
Sell
-116,027
Closed -$32.5M 1021
2024
Q2
$32.5M Buy
116,027
+26,077
+29% +$7.31M ﹤0.01% 1082
2024
Q1
$24M Sell
89,950
-55,639
-38% -$14.9M ﹤0.01% 1208
2023
Q4
$33.7M Sell
145,589
-5,659
-4% -$1.31M 0.01% 1090
2023
Q3
$22.1M Buy
151,248
+15,841
+12% +$2.31M ﹤0.01% 1194
2023
Q2
$31.3M Buy
135,407
+18,816
+16% +$4.35M 0.01% 1065
2023
Q1
$28.2M Buy
116,591
+291
+0.3% +$70.5K 0.01% 1103
2022
Q4
$33.8M Hold
116,300
0.01% 1001
2022
Q3
$7.56M Buy
116,300
+6,794
+6% +$442K ﹤0.01% 1625
2022
Q2
$7.84M Hold
109,506
﹤0.01% 1652
2022
Q1
$10.7M Hold
109,506
﹤0.01% 1680
2021
Q4
$9.28M Buy
109,506
+8,500
+8% +$720K ﹤0.01% 1786
2021
Q3
$8.06M Buy
101,006
+27,347
+37% +$2.18M ﹤0.01% 1822
2021
Q2
$7.18M Sell
73,659
-32,907
-31% -$3.21M ﹤0.01% 1842
2021
Q1
$12.5M Sell
106,566
-42,922
-29% -$5.02M ﹤0.01% 1725
2020
Q4
$16.6M Sell
149,488
-9,994
-6% -$1.11M ﹤0.01% 1626
2020
Q3
$18.9M Buy
159,482
+17,694
+12% +$2.1M 0.01% 1458
2020
Q2
$16.1M Buy
141,788
+9,136
+7% +$1.03M ﹤0.01% 1564
2020
Q1
$8.86M Buy
132,652
+4,107
+3% +$274K ﹤0.01% 1667
2019
Q4
$11.7M Buy
128,545
+41,646
+48% +$3.79M ﹤0.01% 1757
2019
Q3
$7.49M Buy
86,899
+4,549
+6% +$392K ﹤0.01% 1854
2019
Q2
$8.63M Hold
82,350
﹤0.01% 1844
2019
Q1
$10.3M Hold
82,350
﹤0.01% 1789
2018
Q4
$9.28M Buy
82,350
+21,396
+35% +$2.41M ﹤0.01% 1770
2018
Q3
$13.1M Buy
+60,954
New +$13.1M ﹤0.01% 1732
2015
Q3
Sell
-10,714
Closed -$836K 2311
2015
Q2
$836K Hold
10,714
﹤0.01% 2142
2015
Q1
$727K Buy
+10,714
New +$727K ﹤0.01% 2188